Loading clinical trials...
Loading clinical trials...
Patients with cryptogenic focal epilepsy (unknown cause) represent about the 30% of the entire population of epilepsy patients. Among them, about 30% are drug-resistant. The implementation of of high-...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
IRCCS Eugenio Medea
NCT04649008 · Epilepsy, Epilepsy Intractable, and more
NCT05406349 · Epilepsy Intractable
NCT06138808 · Epilepsy Intractable
NCT04286776 · Epilepsy Intractable
NCT06581133 · Epilepsy Intractable
Scientific Institute IRCCS Eugenio Medea
Bosisio Parini, lecco
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions